MEDP
$612.33
▼ −0.46%09/18 O 615.41 H 619.41 L 608.54 C 612.33 ▼ −0.46%
Vol 522.2K RS 79
Vol 522.2K RS 79
RS rating79
Now vs pivot (%)−9.67%
Tightening (ATR ratio)1.53×
Volume dry-up1.47×
Up/down volume, net-0.18
From 52-week high10%
forming
Medpace Holdings, Inc. Common Stock
MEDP · Commercial Physical & Biological Research · $17.1B
Cooling off
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The four are not in order. That is a description of where the averages sit, not a view about what happens next.
The read
The base has run 8.2 weeks and fell 17% from its ceiling at its deepest. The pivot is $677.90, and the stock closed 9.7% below it. Its relative strength rating is 79.
Peers
Catalyst roadmap
- Earningstentativein 31dQuarterly earningsOct 19, 2026
Flagged by the market sweep
Several insiders soldInsider · 2026-09-18
5 insiders sold $66,882,511
Several insiders soldInsider · 2026-09-17
5 insiders sold $51,518,362
Several insiders soldInsider · 2026-09-16
5 insiders sold $51,518,362
Several insiders soldInsider · 2026-09-15
5 insiders sold $51,518,362
Several insiders soldInsider · 2026-09-12
5 insiders sold $51,518,362
Several insiders soldInsider · 2026-09-11
5 insiders sold $51,518,362
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
CON vs. MEDP: Which Stock Is the Better Value Option?Zacks Investment Research · 8 days ago
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray